GUCancers15/Prostate
TARGET AUDIENCE
This activity has been designed to meet the educational needs of medical and radiation oncologists, urologists and other allied healthcare professionals. OVERVIEW OF ACTIVITY These video proceedings from a CME symposium held during the 2015 Genitourinary Cancers Symposium feature discussions with leading PC investigators regarding actual patient cases and related clinical research findings. By providing information on the latest research developments in the context of expert perspectives, this activity will assist medical and radiation oncologists, urologists and other healthcare professionals with the formulation of state-of-the-art clinical management strategies to facilitate optimal care for patients with PC. LEARNING OBJECTIVES
ACCREDITATION STATEMENT CME credit is no longer available for this issue CREDIT DESIGNATION STATEMENT CME credit is no longer available for this issue HOW TO USE THIS CME ACTIVITY CME credit is no longer available for this issue CONTENT VALIDATION AND DISCLOSURES FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a Emmanuel S Antonarakis, MD Advisory Committee: Dendreon Corporation, Janssen Biotech Inc; Consulting Agreements: Astellas Scientific and Medical Affairs Inc, Dendreon Corporation, Janssen Biotech Inc, Sanofi; Contracted Research: Genentech BioOncology, Novartis Pharmaceuticals Corporation, Sanofi, Takeda Oncology; Grant and Research Support: Aragon Pharmaceuticals, Dendreon Corporation, Exelixis Inc, Janssen Biotech Inc, Johnson & Johnson Pharmaceuticals. Andrew J Armstrong, MD, ScM Advisory Committee: Bayer HealthCare Pharmaceuticals; Consulting Agreements: Astellas Scientific and Medical Affairs Inc, Bayer HealthCare Pharmaceuticals, Dendreon Corporation, Janssen Biotech Inc, Sanofi; Contracted Research: Astellas Scientific and Medical Affairs Inc, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Dendreon Corporation, ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company, Janssen Biotech Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Sanofi; Speakers Bureau: Dendreon Corporation. Tomasz M Beer, MD Contracted Research: Astellas Scientific and Medical Affairs Inc, Bristol-Myers Squibb Company, ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company, Novartis Pharmaceuticals Corporation. A Oliver Sartor, MD Consulting Agreements: Astellas Scientific and Medical Affairs Inc, Bavarian Nordic, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, Medivation Inc, Sanofi; Contracted Research: Bayer HealthCare Pharmaceuticals, Progenics Pharmaceuticals Inc, Sanofi. Mary-Ellen Taplin, MD Advisory Committee: Bayer HealthCare Pharmaceuticals, Dendreon Corporation, Janssen Biotech Inc, Medivation Inc, Tokai Pharmaceuticals Inc; Research Funding: Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, Medivation Inc. MODERATOR — Dr Love is president and CEO of Research To Practice, which receives funds in the form of educational grants to develop CME activities from the following commercial interests: AbbVie Inc, Amgen Inc, Astellas Scientific and Medical Affairs Inc, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Biodesix Inc, Boehringer Ingelheim Pharmaceuticals Inc, Boston Biomedical Pharma Inc, Bristol-Myers Squibb Company, Celgene Corporation, Clovis Oncology, Daiichi Sankyo Inc, Dendreon Corporation, Eisai Inc, Exelixis Inc, Foundation Medicine, Genentech BioOncology, Genomic Health Inc, Gilead Sciences Inc, Incyte Corporation, Janssen Biotech Inc, Jazz Pharmaceuticals Inc, Lilly, Medivation Inc, Merck, Myriad Genetic Laboratories Inc, NanoString Technologies, Novartis Pharmaceuticals Corporation, Novocure, Onyx Pharmaceuticals, an Amgen subsidiary, Pharmacyclics Inc, Prometheus Laboratories Inc, Regeneron Pharmaceuticals, Sanofi, Seattle Genetics, Sigma-Tau Pharmaceuticals Inc, Sirtex Medical Ltd, Spectrum Pharmaceuticals Inc, Taiho Oncology Inc, Takeda Oncology, Teva Oncology, Tokai Pharmaceuticals Inc and VisionGate Inc. RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose. This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors. Hardware/Software Requirements: Last review date: July 2015 |